Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
Toshitaka SawamuraShigehiro KarashimaSatoshi NagaseHidetaka NamboEiko ShimizuTakuya HigashitaniDaisuke AonoAzusa OhbatakeMitsuhiro KometaniMasashi DemuraKenji FurukawaYoshiyu TakedaTakashi YonedaPublished in: BMC endocrine disorders (2020)
SGLT2 inhibitor administration yielded minimal effects on ARR and did not increase false-negative results in PA screening in patients with diabetes and hypertension more than 2 months after administration.